BIOGEN INC. DL -,0005 | 230.5500 / +0.79% |
News
- Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone
01/11/2021 / 13:30 - GlobeNewswire - Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec)
01/08/2021 / 13:30 - GlobeNewswire - The European Commission Grants Marketing Authorization for PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis
12/21/2020 / 13:30 - GlobeNewswire - Biogen agrees to $22M settlement to resolve claims on illegal business
12/17/2020 / 20:04 - TeleTrader - Biogen Files New Drug Application for Aducanumab in Japan
12/10/2020 / 04:30 - GlobeNewswire - Artelo Biosciences Announces Appointment of Senior Pharmaceutical Executive Gregory R. Reyes, M.D., Ph.D., to Board of Directors
12/02/2020 / 14:30 - GlobeNewswire - Spero Therapeutics Announces Appointment of Tamara Joseph as Chief Legal Officer
12/02/2020 / 14:30 - GlobeNewswire - Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
11/27/2020 / 13:30 - GlobeNewswire - Samsung Bioepis and Biogen Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis® (ranibizumab)
11/18/2020 / 13:00 - GlobeNewswire - Biogen Ranked #1 Biotechnology Company by Dow Jones Sustainability World Index for an Industry Record 5th Time; Recognition Reflects Longstanding ESG Leadership
11/16/2020 / 13:30 - GlobeNewswire - Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease
11/07/2020 / 02:15 - GlobeNewswire - Biogen surges over 40% on Alzheimer's drug news
11/04/2020 / 18:41 - TeleTrader - Biogen to Present Positive Phase 2 Systemic Lupus Erythematosus Data at American College of Rheumatology 2020 Meeting
11/03/2020 / 13:30 - GlobeNewswire - X4 Pharmaceuticals Appoints Art Taveras, Ph.D., as Chief Scientific Officer
11/02/2020 / 14:00 - GlobeNewswire - European Medicines Agency Accepts Biogen’s Aducanumab Marketing Authorization Application for Alzheimer's Disease
10/30/2020 / 12:00 - GlobeNewswire